2 researchers awarded the 2012 Nobel Prize for stem cell research

By Admin
Share
The British and Japanese researchers namely Sir John Gurdon and Shinya Yamanaka have been awarded 2012 Nobel Prize for stem cell research. The work of...

The British and Japanese researchers namely Sir John Gurdon and Shinya Yamanaka have been awarded 2012 Nobel Prize for stem cell research.

The work of both the researchers has caught the attention of the most famous awards company in the world.

These researchers performed research in nuclear programming, a process that instructs adult cells to form early stem cells which can be then used to form any type of tissue.

A committee at Stockholm’s Karolinska Institute awarded the prize to Gurdon, whose work included taking intestinal samples to clone frogs and Yamanaka, whose work altered genes to reprogram cells.

Mr. John Gurdon showed in his research that genetic information inside the cell gleaned from the intestines of a frog had all the information needed for creating a whole new frog.

 Mr. Yamanaka added four genes to adult skin cells of mice which transformed them into stem cells, which then become specialized cells or iPS cells.

“Such discoveries have provided new tools for scientists around the world and led to remarkable progress in many areas of medicine,” said the Nobel Prize Committee. It also stated, “Gurdon and Yamanaka’s research could revolutionize modern medicine just by using a sample of someone’s skin to create stem cells, that can in turn, hopefully cure disease. Sir Gurdon runs the Gurdon Institute at Cambridge University.

Furthermore, Yamanaka is a professor at Kyoto University in Japan and also works at UCSF. He is also Director of the Center for IPS Cell Research and Application and also a principal investigator at the Institute for Integrated Cell-Material Sciences.

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare